Navigation Links
/C O R R E C T I O N -- Sinovac Biotech Ltd./
Date:11/16/2011

BEIJING, Nov. 16, 2011 /PRNewswire-Asia/ --

In the news release, "Sinovac Reports Unaudited Third Quarter 2011 Financial Results" with financial tables, issued on November 14, 2011 by Sinovac Biotech Ltd. over PR Newswire, we are advised by the Company that the third sentence of the fourth paragraph from the section titled "Financial Review for Third Quarter Ended September 30, 2011" should be read as " Excluding pandemic flu vaccine sales, SG&A as a percentage of sales was 57.7% and 56.1% for the current quarter and prior year quarter, respectively.", rather than "Excluding pandemic flu vaccine sales, SG&A as a percentage of sales was 57.7% and 55.6% for the current quarter and prior year quarter, respectively.", as originally issued inadvertently. And the second sentence of the third paragraph from the section titled "Financial Review for the Nine Months Period Ended September 30, 2011" should read as "After deducting depreciation of land use rights, amortization of licenses, permits, the gross margin was 62.6% and 75.2% for the nine month periods of 2011 and 2010, respectively.", instead of "After deducting depreciation of land use rights, amortization of licenses, permits, the gross margin was 60.3% and 72.9% for the nine month periods of 2011 and 2010, respectively." The third sentence of the fourth paragraph from the section titled "Financial Review for the Nine Months Period Ended September 30, 2011" should read as "Excluding pandemic flu vaccine sales, SG&A as a percentage of sales were 64.2% and 58.6% for the nine-month periods of the current year and prior year, respectively.", instead of  "Excluding pandemic flu vaccine sales, SG&A as a percentage of sales were 64.2% and 58.3% for the nine-month periods of the current year and prior year, respectively." In the Consolidated Balance Sheets, the Total stockholders' equity as of September 30, 2011 should be "$126,159,748" instead of "$126,159,749"; and In the Consolidated Statem
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Sinovac Reports Unaudited Third Quarter 2011 Financial Results
2. Sinovac Reports Positive Preliminary Phase II Clinical Trial Results for EV71 Vaccine Against Hand, Foot and Mouth Disease
3. Sinovac to Host Conference Call to Report Third Quarter 2011 Unaudited Financial Results
4. Sinovac Reports Unaudited Second Quarter 2011 Financial Results
5. Sinovac Announces Management Changes
6. Sinovac Holds 2011 Annual Shareholders Meeting
7. Sinovac Appoints Kenneth Lee to Board of Directors
8. Sinovac Reports Positive Phase I Clinical Trial Results for EV71 Vaccine Candidate Against Hand, Foot & Mouth Disease(HFMD)
9. Sinovac Reports Unaudited First Quarter 2011 Financial Results
10. Sinovac Presents at Two Investor Conferences in May 2011
11. Sinovac Files Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... -- Compass Diversified Holdings (NYSE: CODI ) ("CODI," ... middle market businesses, announced today its consolidated operating results ... 2014. Fourth Quarter 2014 Highlights , ... or "Cash Flow") of $17.5 million for the fourth ... year 2014;  , Reported net income of $8.9 ...
(Date:3/2/2015)... , March 2, 2015  DURECT Corporation ... Epigenomic Regulator Program, and the successful completion of ... lead product candidate DUR-928.  DUR-928 is an endogenous, ... broad applicability in metabolic diseases such as nonalcoholic ... and in acute organ injuries such as acute ...
(Date:3/2/2015)... 2015 Click here for additional information on ... DPLO ), the nation,s largest independent specialty pharmacy, ... 31, 2014. All comparisons, unless otherwise noted, are to the ... Fourth Quarter 2014 Highlights include: , Revenue of ... dispensed of 208,000, an increase of 11% , Gross ...
Breaking Medicine Technology:Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 2Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 3Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 4Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 5Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 6Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 7Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 8Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 9Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 10Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 11Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 12Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 13Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 14Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 15Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 16Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 17Diplomat Announces 4th Quarter and 2014 Year End Financial Results; Provides Initial 2015 Guidance 18
... Inc. (OTCQX: DATA), a technology and services company ... trials industry, today announced its participation in the ... will address significant milestones made throughout the pharmaceutical ... technologies are delivering. The EuroMeeting will be held ...
... Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) ... launch of its new formulation of Acetadote ® ... treat acetaminophen poisoning. The proprietary new formulation, which does ... other stabilization or chelating agents, is now stocked at ...
Cached Medicine Technology:DATATRAK to Attend DIA's 23rd Annual EuroMeeting 2New Acetadote® Formulation Now Available in the U.S. 2New Acetadote® Formulation Now Available in the U.S. 3New Acetadote® Formulation Now Available in the U.S. 4
(Date:3/2/2015)... Market Publishers Ltd is extremely happy to ... Industry Analysts Inc and recently added to its catalogue. ... Through 2018, the global radiation therapy equipment market is ... report suggests a holistic analysis of the situation in ... as covers the top market trends. The publication uncovers ...
(Date:3/2/2015)... “ Wants and Needs ” was featured on ... the latest and coolest mobile applications on the iOS, ... expert and host of NewsWatch, conducted the app review ... evaluate priorities. , Whether a person needs help re-orienting ... The app allows people to enter and track wants, ...
(Date:3/2/2015)... Doctors in Novara, Italy have found ... of outcomes for people with mesothelioma than other clinical ... the new study on the Surviving Mesothelioma website. ... Eastern Piedmont followed the cases of 172 mesothelioma ... lung fluid. , “Persistent lung expansion after pleural ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Robins & ... In conjunction with Women in Construction Week (March 1-7, ... or NAWIC) and National Women’s History Month, Robins & ... positively affect the company and the construction industry as ... team, to the dozens of roles in between, each ...
(Date:3/2/2015)... 2015 New York singer/songwriter Richie ... delivering a plenary address entitled Finding the Music ... of Healing and Recovery at this year’s National ... Executive Summit (BHES).     , With more than 300 ... been recorded by some of the biggest names ...
Breaking Medicine News(10 mins):Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 2Health News:New Topical Research Reports Prepared by GIA Now Available at MarketPublishers.com 3Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:Richie Supa Announced as a Plenary Speaker at NCAD 2015 2
... Day Keeps the Doctor Away - Using QlikView, Inside Info has ... tracking the progression of diseases in the community through more effective ... said Jon Marshall, Managing Director, asteRx. , ... ...
... publisher, Healthcommunities.com, Inc., announces recent additions to urologychannel.com, its urologic ... extensive STD information section, will help people with ... prevent STD complications. , ... Northhampton, ...
... Service Dog Eye Exam event is highly successful in pairing veterinary ophthalmologists ... ... (Vocus) May 20, 2009 -- She has been blind for 13 years. ... ACVO/Merial National Service Dog Eye Exam event , she was elated. ...
... Counter top converts to under counter system. Under counter ionizer converts to counter ... ... health benefits of ionized and alkaline mineral water at home or ... of convertible water ionizers launched by Life Ionizers., , , , ,The company ...
... Wellness Center, one of the nation,s leaders in diagnosing and treating Lyme ... information on the accurate diagnosis and treatment and cure of this highly ... ... The Haverford Wellness Center officially launched a new web site today ...
... Atrophy has just launched a new Medical Advisory Council (MAC). ... most highly respected bodies of SMA medical and clinical experts ... collaborative leadership on issues that improve the quality of medical ... focus on educating families, health care providers, and the public ...
Cached Medicine News:Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 2Health News:Innovative Business Intelligence Software Helps Keep Australia Healthy this Winter 3Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 2Health News:Valuable New Resources for Treating Sexually Transmitted Disease (STD) 3Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 2Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 3Health News:More Than 1,500 Service Dogs Receive Free Sight Saving Eye Exams 4Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 2Health News:Life Ionizers Promotes Convenience and Healthy Lifestyles With New Convertible Water Ionizers Line 3Health News:Haverford Wellness Center Launches Web Site Devoted to Accurate Diagnosis and Proper Treatment to Cure Lyme Disease 2Health News:Haverford Wellness Center Launches Web Site Devoted to Accurate Diagnosis and Proper Treatment to Cure Lyme Disease 3Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 2Health News:Families of Spinal Muscular Atrophy Announces its New Medical Advisory Council 3
... X-22 Series is up to 10 inches/ 25 cm ... 11 rotors, the Allegra X-22 Series is the space-saving ... Only 18 inches / 46 cm wide • 11 ... 3 different ways to Spin 1.5 mL & ...
... purpose centrifuges offer high-volume versatility along with ... making them ideal for a wide variety ... Four- or six-place sealed swinging bucket ... rotors offered , Lare capacity (4 x ...
... high performance centrifuge designed to accommodate over ... is refrigerated for heat labile samples. Incorporating ... refrigerated capability with automatic quick cooling from ... 7 min, no maintenance brushless motor, low ...
Inquire...
Medicine Products: